GlaxoSmithKline taps Baltimore’s Insilico for AI-based drug discovery

GlaxoSmithKline and Insilico Medicine are partnering to explore how the latter’s artificial intelligence technology c | GlaxoSmithKline and Insilico Medicine are partnering to explore how the latter’s artificial intelligence technology can aid in the drug discovery process.